Details of the Drug
General Information of Drug (ID: DMH4AGL)
Drug Name |
Tetraethylene Glycol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
TETRAETHYLENE GLYCOL; 112-60-7; Tetraglycol; 2,2'-((Oxybis(ethane-2,1-diyl))bis(oxy))diethanol; HI-Dry; Carbitol, diethyl; 3,6,9-Trioxaundecane-1,11-diol; Ethanol, 2,2'-[oxybis(2,1-ethanediyloxy)]bis-; Tetra(ethylene glycol); NSC 1262; 2,2'-[oxybis(ethane-2,1-diyloxy)]diethanol; Bis[2-(2-hydroxyethoxy)ethyl] ether; HSDB 843; Ethanol, 2,2'-(oxybis(ethyleneoxy))di-; 3,6,9-Trioxaundecan-1,11-diol; EINECS 203-989-9; BRN 1634320; PEG-4; AI3-01838; 2,2'-[oxybis(2,1-ethanediyloxy)]diethanol; CHEBI:44920; UWHCKJMYHZGTIT-UHFFFAOYSA-N
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 194.23 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 10 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||